The Similarities and Differences between Intracranial and Spinal Ependymomas : A Review from a Genetic Research Perspective |
Lee, Chang-Hyun
(Department of Neurosurgery, Ilsan Paik Hospital, Inje University College of Medicine)
Chung, Chun Kee (Department of Neurosurgery, Seoul National University Hospital) Ohn, Jung Hun (Bioinformatics, Samsung Gene Institute, Samsung Medical Center) Kim, Chi Heon (Department of Neurosurgery, Seoul National University Hospital) |
1 | Magrassi L, Conti L, Lanterna A, Zuccato C, Marchionni M, Cassini P, et al. : Shc3 affects human high-grade astrocytomas survival. Oncogene 24 : 5198-5206, 2005 DOI |
2 | Magrassi L, Marziliano N, Inzani F, Cassini P, Chiaranda I, Skrap M, et al. : EDG3 and SHC3 on chromosome 9q22 are co-amplified in human ependymomas. Cancer Lett 290 : 36-42, 2010 DOI |
3 | Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, et al. : Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24 : 5223-5233, 2006 DOI |
4 | Monoranu CM, Huang B, Zangen IL, Rutkowski S, Vince GH, Gerber NU, et al. : Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet 182 : 18-26, 2008 DOI |
5 | Olsen TK, Gorunova L, Meling TR, Micci F, Scheie D, Due-Tonnessen B, et al. : Genomic characterization of ependymomas reveals 6q loss as the most common aberration. Oncol Rep 32 : 483-490, 2014 DOI |
6 | Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, et al. : Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27 : 728-743, 2015 DOI |
7 | Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y, et al. : C11orf95-RELA fusions drive oncogenic NF- signalling in ependymoma. Nature 506 : 451-455, 2014 DOI |
8 | Rajaram V, Leuthardt EC, Singh PK, Ojemann JG, Brat DJ, Prayson RA, et al. : 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases. Mod Pathol 17 : 9-14, 2004 DOI |
9 | Puget S, Grill J, Valent A, Bieche I, Dantas-Barbosa C, Kauffmann A, et al. : Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas. J Clin Oncol 27 : 1884-1892, 2009 DOI |
10 | Rajaram V, Gutmann DH, Prasad SK, Mansur DB, Perry A : Alterations of protein 4.1 family members in ependymomas : a study of 84 cases. Mod Pathol 18 : 991-997, 2005 DOI |
11 | Sherr CJ : The INK4a/ARF network in tumour suppression. Rev Mol Cell Biol 2 : 731-737, 2001 DOI |
12 | Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, Herndon JE 2nd, et al. : Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors : phase II study results. J Clin Oncol 24 : 115-122, 2006 DOI |
13 | Rogers HA, Kilday JP, Mayne C, Ward J, Adamowicz-Brice M, Schwalbe EC, et al. : Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death. Acta Neuropathol 123 : 711-725, 2012 DOI |
14 | Rubio MP, Correa KM, Ramesh V, MacCollin MM, Jacoby LB, von Deimling A, et al. : Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas. Cancer Res 54 : 45-47, 1994 |
15 | Scheil S, Bruderlein S, Eicker M, Herms J, Herold-Mende C, Steiner HH, et al. : Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 11 : 133-143, 2001 |
16 | Schneider D, Monoranu CM, Huang B, Rutkowski S, Gerber NU, Krauss J, et al. : Pediatric supratentorial ependymomas show more frequent deletions on chromosome 9 than infratentorial ependymomas : a microsatellite analysis. Cancer Genet Cytogenet 191 : 90-96, 2009 DOI |
17 | Singh PK, Gutmann DH, Fuller CE, Newsham IF, Perry A : Differential involvement of protein 4.1 family members DAL-1 and NF2 in intracranial and intraspinal ependymomas. Mod Pathol 15 : 526-531, 2002 DOI |
18 | Suzuki SO, Iwaki T : Amplification and overexpression of mdm2 gene in ependymomas. Mod Pathol 13 : 548-553, 2000 DOI |
19 | Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, et al. : Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8 : 323-335, 2005 DOI |
20 | Teo C, Nakaji P, Symons P, Tobias V, Cohn R, Smee R : Ependymoma. Childs Nerv Syst 19 : 270-285, 2003 DOI |
21 | Barton VN, Donson AM, Kleinschmidt-DeMasters BK, Birks DK, Handler MH, Foreman NK : Unique molecular characteristics of pediatric myxopapillary ependymoma. Brain Pathol 20 : 560-570, 2010 DOI |
22 | Ahmad ZK, Brown CM, Cueva RA, Ryan AF, Doherty JK : ErbB expression, activation, and inhibition with lapatinib and tyrphostin (AG825) in human vestibular schwannomas. Otol Neurotol 32 : 841-847, 2011 DOI |
23 | Andreiuolo F, Puget S, Peyre M, Dantas-Barbosa C, Boddaert N, Philippe C, et al. : Neuronal differentiation distinguishes supratentorial and infratentorial childhood ependymomas. Neuro Oncol 12 : 1126-1134, 2010 DOI |
24 | Athanasiou A, Perunovic B, Quilty RD, Gorgoulis VG, Kittas C, Love S : Expression of mos in ependymal gliomas. Am J Clin Pathol 120 : 699-705, 2003 DOI |
25 | Wang Z, Zhang J, Ye M, Zhu M, Zhang B, Roy M, et al. : Tumor suppressor role of protein 4.1B/DAL-1. Cell Mol Life Sci 71 : 4815-4830, 2014 DOI |
26 | Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, Necesito-Reyes MJ, et al. : Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients. Neuro Oncol 17 : 440-447, 2015 DOI |
27 | von Haken MS, White EC, Daneshvar-Shyesther L, Sih S, Choi E, Kalra R, et al. : Molecular genetic analysis of chromosome arm 17p and chromosome arm 22q DNA sequences in sporadic pediatric ependymomas. Genes Chromosomes Cancer 17 : 37-44, 1996 DOI |
28 | Waha A, Koch A, Hartmann W, Mack H, Schramm J, Sorensen N, et al. : Analysis of HIC-1 methylation and transcription in human ependymomas. Int J Cancer 110 : 542-549, 2004 DOI |
29 | Wani K, Armstrong TS, Vera-Bolanos E, Raghunathan A, Ellison D, Gilbertson R, et al. : A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol 123 : 727-738, 2012 DOI |
30 | Ward S, Harding B, Wilkins P, Harkness W, Hayward R, Darling JL, et al. : Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32 : 59-66, 2001 DOI |
31 | Witt H, Mack SC, Ryzhova M, Bender S, Sill M, Isserlin R, et al. : Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20 : 143-157, 2011 DOI |
32 | Yang I, Nagasawa DT, Kim W, Spasic M, Trang A, Lu DC, et al. : Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas. J Clin Neurosci 19 : 779-785, 2012 DOI |
33 | Zadnik PL, Gokaslan ZL, Burger PC, Bettegowda C : Spinal cord tumours : advances in genetics and their implications for treatment. Nat Rev Neurol 9 : 257-266, 2013 |
34 | Fink KL, Rushing EJ, Schold SC Jr, Nisen PD : Infrequency of p53 gene mutations in ependymomas. J Neurooncol 27 : 111-115, 1996 |
35 | Bettegowda C, Agrawal N, Jiao Y, Wang Y, Wood LD, Rodriguez FJ, et al. : Exomic sequencing of four rare central nervous system tumor types. Oncotarget 4 : 572-583, 2013 DOI |
36 | de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R : Biological background of pediatric medulloblastoma and ependymoma : a review from a translational research perspective. Neuro Oncol 10 : 1040-1060, 2008 DOI |
37 | Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, et al. : Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155 : 627-632, 1999 DOI |
38 | Garcia C, Gutmann DH : Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner. PLoS One 9 : e97320, 2014 DOI |
39 | Gilbertson RJ, Bentley L, Hernan R, Junttila TT, Frank AJ, Haapasalo H, et al. : ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res 8 : 3054-3064, 2002 |
40 | Gonzalez-Gomez P, Bello MJ, Alonso ME, Arjona D, Lomas J, de Campos JM, et al. : CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours. Br J Cancer 88 : 109-114, 2003 DOI |
41 | Gupta RK, Sharma MC, Suri V, Kakkar A, Singh M, Sarkar C : Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas. J Neurooncol 116 : 267-274, 2014 DOI |
42 | Zheng PP, Pang JC, Hui AB, Ng HK : Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. Cancer Genet Cytogenet 122 : 18-25, 2000 DOI |
43 | Zhou XP, Li YJ, Hoang-Xuan K, Laurent-Puig P, Mokhtari K, Longy M, et al. : Mutational analysis of the PTEN gene in gliomas : molecular and pathological correlations. Int J Cancer 84 : 150-154, 1999 DOI |
44 | Kilday JP, Rahman R, Dyer S, Ridley L, Lowe J, Coyle B, et al. : Pediatric ependymoma : biological perspectives. Mol Cancer Res 7 : 765-786, 2009 DOI |
45 | Hagel C, Treszl A, Fehlert J, Harder J, von Haxthausen F, Kern M, et al. : Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression. J Neurooncol 112 : 191-197, 2013 DOI |
46 | Hamilton DW, Lusher ME, Lindsey JC, Ellison DW, Clifford SC : Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. Cancer Lett 227 : 75-81, 2005 DOI |
47 | Huang B, Starostik P, Kuhl J, Tonn JC, Roggendorf W : Loss of heterozygosity on chromosome 22 in human ependymomas. Acta Neuropathol 103 : 415-420, 2002 DOI |
48 | Huang B, Starostik P, Schraut H, Krauss J, Sorensen N, Roggendorf W : Human ependymomas reveal frequent deletions on chromosomes 6 and 9. Acta Neuropathol 106 : 357-362, 2003 DOI |
49 | Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, et al. : Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466 : 632-636, 2010 DOI |
50 | Korshunov A, Witt H, Hielscher T, Benner A, Remke M, Ryzhova M, et al. : Molecular staging of intracranial ependymoma in children and adults. J Clin Oncol 28 : 3182-3190, 2010 DOI |
51 | Kraus JA, de Millas W, Sorensen N, Herbold C, Schichor C, Tonn JC, et al. : Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Acta Neuropathol 102 : 69-74, 2001 |
52 | Lamszus K, Lachenmayer L, Heinemann U, Kluwe L, Finckh U, Hoppner W, et al. : Molecular genetic alterations on chromosomes 11 and 22 in ependymomas. Int J Cancer 91 : 803-808, 2001 DOI |